Iobenguane
- TRADE NAME: AdreView (GE Healthcare)
- INDICATIONS: Detection of primary or metastatic pheochromocytoma or neuroblastoma as an adjunct to other diagnostic tests
- SYNONYM: metaiodobenzylguanidine; MIBG
- CLASS: Radiopharmaceutical, diagnostic agent
- HALF-LIFE: 13 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Amitriptyline, Amoxapine, Citalopram, Cocaine, Duloxetine, Ephedrine, Formoterol, Formoterol, Imipramine, Labetalol, Levalbuterol, Lisdexamfetamine, Phenylephrine, Phenylpropanolamine, Pseudoephedrine, Reserpine, Salmeterol, SSRIs, Terbutaline
PREGNANCY CATEGORY: C
Please login to see the rest of this drug profile
SKIN.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
ENDOCRINE/METABOLIC.
HEMATOLOGIC.
LOCAL.
RESPIRATORY.
OTHER.
Page last updated 07/31/2023
Symbol key
Incidence
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric